schliessen

Filtern

 

Bibliotheken

Patterns of distant metastasis in Chinese women according to breast cancer subtypes

To access possible relationships between breast cancer subtypes (BCS) and patterns of distant metastasis in advanced breast cancer. Breast cancer patients with distant metastasis at two academic centers from 2000-2015 were retrospectively reviewed. The breast cancer was classified into four subtypes... Full description

Journal Title: Oncotarget 26 July 2016, Vol.7(30), pp.47975-47984
Main Author: Wu, San-Gang
Other Authors: Sun, Jia-Yuan , Yang, Li-Chao , Tang, Li-Ying , Wang, Xue , Chen, Xue-Ting , Liu, Gui-Hua , Lin, Huan-Xin , Lin, Qin , He, Zhen-Yu
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: E-ISSN: 1949-2553 ; PMID: 27322074 Version:1 ; DOI: 10.18632/oncotarget.10099
Link: http://pubmed.gov/27322074
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: medline27322074
title: Patterns of distant metastasis in Chinese women according to breast cancer subtypes
format: Article
creator:
  • Wu, San-Gang
  • Sun, Jia-Yuan
  • Yang, Li-Chao
  • Tang, Li-Ying
  • Wang, Xue
  • Chen, Xue-Ting
  • Liu, Gui-Hua
  • Lin, Huan-Xin
  • Lin, Qin
  • He, Zhen-Yu
subjects:
  • Breast Cancer
  • Breast Cancer Subtype
  • Distant Metastasis
  • Patterns
  • Breast Neoplasms -- Pathology
ispartof: Oncotarget, 26 July 2016, Vol.7(30), pp.47975-47984
description: To access possible relationships between breast cancer subtypes (BCS) and patterns of distant metastasis in advanced breast cancer. Breast cancer patients with distant metastasis at two academic centers from 2000-2015 were retrospectively reviewed. The breast cancer was classified into four subtypes: hormone receptor (HR) +/ human epidermal growth factor receptor 2 (HER2) - (i.e., estrogen receptor [ER] + and/or progesterone receptor [PR] +, HER2-); HR+/HER2+ (ER+ and/or PR+, HER2+), HR-/HER2+ (ER- and PR-, and HER2+); and HR-/HER2- (ER- and PR-, and HER2-). A total of 679 patients were identified. The distribution of the BCS was 39.9% (271/679), 23.7% (161/679), 16.8% (114/679), and 19.6% (133/679) in HR+/HER2-, HR+/HER2+, HR-/HER2+, and HR-/HER2-, respectively. Patients with HR+/HER2+ and HR-/HER2+ subtypes were prone to abdominal and pelvic metastasis, those with HR+/HER2- and HR+/HER2+ subtypes were prone to bone metastasis, while patients with the HR-/HER2- subtype were prone to lung/mediastinal...
language: eng
source:
identifier: E-ISSN: 1949-2553 ; PMID: 27322074 Version:1 ; DOI: 10.18632/oncotarget.10099
fulltext: fulltext
issn:
  • 19492553
  • 1949-2553
url: Link


@attributes
ID1729263396
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid27322074
sourceidmedline
recordidTN_medline27322074
sourceformatXML
sourcesystemPC
pqid1826702616
display
typearticle
titlePatterns of distant metastasis in Chinese women according to breast cancer subtypes
creatorWu, San-Gang ; Sun, Jia-Yuan ; Yang, Li-Chao ; Tang, Li-Ying ; Wang, Xue ; Chen, Xue-Ting ; Liu, Gui-Hua ; Lin, Huan-Xin ; Lin, Qin ; He, Zhen-Yu
ispartofOncotarget, 26 July 2016, Vol.7(30), pp.47975-47984
identifier
subjectBreast Cancer ; Breast Cancer Subtype ; Distant Metastasis ; Patterns ; Breast Neoplasms -- Pathology
descriptionTo access possible relationships between breast cancer subtypes (BCS) and patterns of distant metastasis in advanced breast cancer. Breast cancer patients with distant metastasis at two academic centers from 2000-2015 were retrospectively reviewed. The breast cancer was classified into four subtypes: hormone receptor (HR) +/ human epidermal growth factor receptor 2 (HER2) - (i.e., estrogen receptor [ER] + and/or progesterone receptor [PR] +, HER2-); HR+/HER2+ (ER+ and/or PR+, HER2+), HR-/HER2+ (ER- and PR-, and HER2+); and HR-/HER2- (ER- and PR-, and HER2-). A total of 679 patients were identified. The distribution of the BCS was 39.9% (271/679), 23.7% (161/679), 16.8% (114/679), and 19.6% (133/679) in HR+/HER2-, HR+/HER2+, HR-/HER2+, and HR-/HER2-, respectively. Patients with HR+/HER2+ and HR-/HER2+ subtypes were prone to abdominal and pelvic metastasis, those with HR+/HER2- and HR+/HER2+ subtypes were prone to bone metastasis, while patients with the HR-/HER2- subtype were prone to lung/mediastinal...
languageeng
source
version3
lds50peer_reviewed
links
openurl$$Topenurl_article
backlink$$Uhttp://pubmed.gov/27322074$$EView_this_record_in_MEDLINE/PubMed
openurlfulltext$$Topenurlfull_article
addlink$$Uhttp://exlibris-pub.s3.amazonaws.com/aboutMedline.html$$EView_the_MEDLINE/PubMed_Copyright_Statement
search
creatorcontrib
0Wu, San-Gang
1Sun, Jia-Yuan
2Yang, Li-Chao
3Tang, Li-Ying
4Wang, Xue
5Chen, Xue-Ting
6Liu, Gui-Hua
7Lin, Huan-Xin
8Lin, Qin
9He, Zhen-Yu
titlePatterns of distant metastasis in Chinese women according to breast cancer subtypes
descriptionTo access possible relationships between breast cancer subtypes (BCS) and patterns of distant metastasis in advanced breast cancer. Breast cancer patients with distant metastasis at two academic centers from 2000-2015 were retrospectively reviewed. The breast cancer was classified into four subtypes: hormone receptor (HR) +/ human epidermal growth factor receptor 2 (HER2) - (i.e., estrogen receptor [ER] + and/or progesterone receptor [PR] +, HER2-); HR+/HER2+ (ER+ and/or PR+, HER2+), HR-/HER2+ (ER- and PR-, and HER2+); and HR-/HER2- (ER- and PR-, and HER2-). A total of 679 patients were identified. The distribution of the BCS was 39.9% (271/679), 23.7% (161/679), 16.8% (114/679), and 19.6% (133/679) in HR+/HER2-, HR+/HER2+, HR-/HER2+, and HR-/HER2-, respectively. Patients with HR+/HER2+ and HR-/HER2+ subtypes were prone to abdominal and pelvic metastasis, those with HR+/HER2- and HR+/HER2+ subtypes were prone to bone metastasis, while patients with the HR-/HER2- subtype were prone to lung/mediastinal...
subject
0Breast Cancer
1Breast Cancer Subtype
2Distant Metastasis
3Patterns
4Breast Neoplasms -- Pathology
general
027322074
1English
2MEDLINE/PubMed (U.S. National Library of Medicine)
310.18632/oncotarget.10099
4MEDLINE/PubMed (NLM)
sourceidmedline
recordidmedline27322074
issn
019492553
11949-2553
rsrctypearticle
creationdate2016
addtitleOncotarget
searchscope
0medline
1nlm_medline
2MEDLINE
scope
0medline
1nlm_medline
2MEDLINE
lsr41201626
citationpf 47975 vol 7 issue 30
startdate20160726
enddate20160726
lsr30VSR-Enriched:[pqid]
sort
titlePatterns of distant metastasis in Chinese women according to breast cancer subtypes
authorWu, San-Gang ; Sun, Jia-Yuan ; Yang, Li-Chao ; Tang, Li-Ying ; Wang, Xue ; Chen, Xue-Ting ; Liu, Gui-Hua ; Lin, Huan-Xin ; Lin, Qin ; He, Zhen-Yu
creationdate20160726
lso0120160726
facets
frbrgroupid-1987719427632327595
frbrtype5
newrecords20190701
languageeng
creationdate2016
topic
0Breast Cancer
1Breast Cancer Subtype
2Distant Metastasis
3Patterns
4Breast Neoplasms–Pathology
collectionMEDLINE/PubMed (NLM)
prefilterarticles
rsrctypearticles
creatorcontrib
0Wu, San-Gang
1Sun, Jia-Yuan
2Yang, Li-Chao
3Tang, Li-Ying
4Wang, Xue
5Chen, Xue-Ting
6Liu, Gui-Hua
7Lin, Huan-Xin
8Lin, Qin
9He, Zhen-Yu
jtitleOncotarget
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Wu
1Sun
2Yang
3Tang
4Wang
5Chen
6Liu
7Lin
8He
aufirst
0San-Gang
1Jia-Yuan
2Li-Chao
3Li-Ying
4Xue
5Xue-Ting
6Gui-Hua
7Huan-Xin
8Qin
9Zhen-Yu
au
0Wu, San-Gang
1Sun, Jia-Yuan
2Yang, Li-Chao
3Tang, Li-Ying
4Wang, Xue
5Chen, Xue-Ting
6Liu, Gui-Hua
7Lin, Huan-Xin
8Lin, Qin
9He, Zhen-Yu
atitlePatterns of distant metastasis in Chinese women according to breast cancer subtypes
jtitleOncotarget
risdate20160726
volume7
issue30
spage47975
pages47975-47984
issn1949-2553
eissn1949-2553
formatjournal
genrearticle
ristypeJOUR
abstractTo access possible relationships between breast cancer subtypes (BCS) and patterns of distant metastasis in advanced breast cancer. Breast cancer patients with distant metastasis at two academic centers from 2000-2015 were retrospectively reviewed. The breast cancer was classified into four subtypes: hormone receptor (HR) +/ human epidermal growth factor receptor 2 (HER2) - (i.e., estrogen receptor [ER] + and/or progesterone receptor [PR] +, HER2-); HR+/HER2+ (ER+ and/or PR+, HER2+), HR-/HER2+ (ER- and PR-, and HER2+); and HR-/HER2- (ER- and PR-, and HER2-). A total of 679 patients were identified. The distribution of the BCS was 39.9% (271/679), 23.7% (161/679), 16.8% (114/679), and 19.6% (133/679) in HR+/HER2-, HR+/HER2+, HR-/HER2+, and HR-/HER2-, respectively. Patients with HR+/HER2+ and HR-/HER2+ subtypes were prone to abdominal and pelvic metastasis, those with HR+/HER2- and HR+/HER2+ subtypes were prone to bone metastasis, while patients with the HR-/HER2- subtype were prone to lung/mediastinal...
doi10.18632/oncotarget.10099
pmid27322074
date2016-07-26